|
 
|
Robert
S. Langer, Ph.D.
Germeshausen Professor of Chemical and Biomedical Engineering
Research group web
site
Email: rlanger@mit.edu
Office: E25-342
Phone: (617) 253-3107
Fax: (617) 258-8827
Research Laboratory Administrator: Constance
J. Beal
Administrative Assistants: Ilda
Thompson and Nancy Parkinson
Phone: 617-253-3123 Fax: 617-258-8827
Courses: 20.02S, 10.984, 10.02J, 10.491 |
Research Focus
Drug Delivery, Biotechnology, Immobilized
Enzymes, Biomedical Engineering
Our work is at the interface of bio-technology and materials science.
A major focus is the study and development of polymers to deliver
drugs, particularly genetically engineered proteins, continuously
at controlled rates and for prolonged periods of time. Work in progress
in several areas including:
- Investigating the mechanism of release from polymeric delivery
systems with concomitant microstructural analysis and mathematical
modeling.
- Studying applications of these systems including the development
of effective long-term delivery systems for insulin, interferon,
growth hormones and vaccines.
- Developing controlled release systems that can be magnetically,
ultrasonically, or enzymatically triggered to increase release
rates.
- Synthesizing new biodegradable polymeric delivery systems which
will ultimately be absorbed by the body.
- Creating new approaches for delivering drugs across complex
barriers in the body such as the blood-brain barrier and the skin.
- Synthesizing new biodegradable polymer systems to be used in
mammalian cell transplants for engineering new organs (e.g. the
liver, cartilage).
Our interest in drug delivery systems has extended to situations
where drugs may serve a potentially useful purpose and then cause
toxicity. In such cases, it would be useful to have a selective
drug or substance removal system. Examples include removal of heparin,
bilirubin, and cholesterol. All of these studies involve reactor
design, understanding biomaterials with respect to blood interactions,
and modeling of in vivo situations.
Finally we are developing drugs that specifically inhibit the process
of neovascularization but do not interfere with existing blood vessels.
Neovascularization is critical to the progression of several diseases,
including cancer, retinopathy, rheumatoid arthritis and psoriasis.
These projects involve biochemical purification and tissue culture
studies.
Selected Publications
Click
here for a complete list of publications.
1. Lahann, J., Mitragotri, S., Tran, T., Kaido, H., Sundaran, J.,
Hoffer, S., Somorjai, G. A., Langer, R. Reversible switching of
surfaces, Science, 299: 371-374, 2003.
2. Lee, P., Langer, R., Shastri, V., Novel microemulsion enhancer
formulation for simultaneous transdermal delivery of hydrophilic
and hydrophobic drugs, Pharmaceutical Research, 20: 261-266, 2003.
3. Sasiskharan, R., Rational design of low molecular weight heparins
with improved in vivo activity, PNAS, 100: 651-656, 2003.
4. Radisic M., Euloth M., Yang L., Langer R., Freed L.E., Vunjak-Novaakovic
G, High density seeding of myocyte cells for tissue engineering,
Biotech. & Bioeng., 82: 403-414, 2003.
5. Langer, R. Where a pill won’t go, Scientific American,
288: 50-57, 2003.
6. LaVan, D., George, P.M, Langer, R., Simple three-dimensional
microfabrication of electrodeposited structures, Angewandte Chemie,
42: 1262-1265, 2003.
7. Yu, B., Kim, K.H., So, P.T.C., Blankschtein, D., Langer, R,
Visualization of oleic acid-induced transdermal diffusion pathways
using two-photon fluorescence microscopy., Journal of Invest. Derm.,
120: 448-455, 2003.
8. Fu, K., Harrell, R., Zinski, K., Um, C., Frazier, J., Lotan,
N., Burke, P., Klibanov, A., Langer, R., A Potential Approach for
Decreasing the Burst Effect of Protein from PLGA Microspheres, Journal
of Pharm. Sci., 92: 1582-1591, 2003.
9. Lendlein, A., and Langer, R., Biodegradable, Elastic Thermoplastic
Shape Memory Polymers with Adjustable properties for potential biomedical
applications, Science, 296: 1673-1676, 2002.
10. Langer, R., Perspectives: Drug delivery – drugs on target,
Science, 293: 58-59, 2001.
11. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser,
S., Marini, R., Langer, R., Functional arteries grown in vitro,
Science, 284, 489-493, 1999.
12. Santini, J.T. Jr., Cima, M.J., and Langer, R.: A controlled
release microchip, Nature, 397- 335-338, 1999.
13. Langer, R., Langer, R., Drug delivery and targeting, Nature,
392 (Suppl), 5-10, 1998.
14. Langer, R., New methods of drug delivery, Science, 249, 1527-1533,
1990.
15. Langer, R. and Tirrell, D., Novel biomaterials, Nature, in
press.
top |